173 related articles for article (PubMed ID: 33114668)
1. Design and Synthesis of Various 5'-Deoxy-5'-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of
Hervin V; Arora R; Rani J; Ramchandran S; Bajpai U; Agrofoglio LA; Roy V
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114668
[TBL] [Abstract][Full Text] [Related]
2. Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.
Eniyan K; Kumar A; Rayasam GV; Perdih A; Bajpai U
Sci Rep; 2016 Oct; 6():35134. PubMed ID: 27734910
[TBL] [Abstract][Full Text] [Related]
3. The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall.
Shinde Y; Ahmad I; Surana S; Patel H
Eur J Med Chem; 2021 Oct; 222():113568. PubMed ID: 34118719
[TBL] [Abstract][Full Text] [Related]
4. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.
Hrast M; Turk S; Sosič I; Knez D; Randall CP; Barreteau H; Contreras-Martel C; Dessen A; O'Neill AJ; Mengin-Lecreulx D; Blanot D; Gobec S
Eur J Med Chem; 2013 Aug; 66():32-45. PubMed ID: 23786712
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF.
Sova M; Kovac A; Turk S; Hrast M; Blanot D; Gobec S
Bioorg Chem; 2009 Dec; 37(6):217-22. PubMed ID: 19804894
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
8. Essential residues for the enzyme activity of ATP-dependent MurE ligase from Mycobacterium tuberculosis.
Basavannacharya C; Moody PR; Munshi T; Cronin N; Keep NH; Bhakta S
Protein Cell; 2010 Nov; 1(11):1011-22. PubMed ID: 21153518
[TBL] [Abstract][Full Text] [Related]
9. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.
Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436
[TBL] [Abstract][Full Text] [Related]
10. 5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.
Fer MJ; Bouhss A; Patrão M; Le Corre L; Pietrancosta N; Amoroso A; Joris B; Mengin-Lecreulx D; Calvet-Vitale S; Gravier-Pelletier C
Org Biomol Chem; 2015 Jul; 13(26):7193-222. PubMed ID: 26008868
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
[TBL] [Abstract][Full Text] [Related]
12. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Sansanmycin Analogues as Potent
Tran W; Kusay AS; Hawkins PME; Cheung CY; Nagalingam G; Pujari V; Ford DJ; Stoye A; Ochoa JL; Audette RE; Hortle E; Oehlers SH; Charman SA; Linington RG; Rubin EJ; Dowson CG; Roper DI; Crick DC; Balle T; Cook GM; Britton WJ; Payne RJ
J Med Chem; 2021 Dec; 64(23):17326-17345. PubMed ID: 34845906
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor.
Paradis-Bleau C; Lloyd A; Sanschagrin F; Maaroufi H; Clarke T; Blewett A; Dowson C; Roper DI; Bugg TD; Levesque RC
Biochem J; 2009 Jun; 421(2):263-72. PubMed ID: 19400768
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
[TBL] [Abstract][Full Text] [Related]
17. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
[TBL] [Abstract][Full Text] [Related]
18. Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE).
Strancar K; Boniface A; Blanot D; Gobec S
Arch Pharm (Weinheim); 2007 Mar; 340(3):127-34. PubMed ID: 17335103
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 2'-deoxy-2'-[(1,2,3)triazol-1-yl]uridines using click chemistry approach.
Kumar S
Nucleosides Nucleotides Nucleic Acids; 2015; 34(5):371-8. PubMed ID: 25874945
[TBL] [Abstract][Full Text] [Related]
20. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
